Abstract:Objective To comparatively analyze the relationship of peak-echo intensity of targeted ultrasound molecular imaging and asialoglycoprotein receptor(ASGPR) content in different degree of rat acute liver injury.Methods Acute liver injury model was established by intraperitoneal infusion of carbon tetrachloride(CCl4) in 45 healthy male SD rats,the rats were divided into 5 groups(groupⅠ～groupⅤ)according to doses of CCl4(10%,20%,30%,40%,50%)with 9 rats in each group.The content of liver ASGPR in 4 rats of each group was detected respectively.The others were anesthetized generally,thoracic and abdominal skin was prepared,the liquid perfluorocarbon nanoparticles targeted ultrasound contrast agents were injected through the tail vein with bolus injection.From the beginning to 0.5 h,the ultrasonic imaging was observed and recorded continuously;from 0.5 h to 1 h,the ultrasonic imaging was observed and recorded in each 10 min;from 1 h to the regression of contrast agents,the ultrasonic imaging of the liver parenchyma was observed and recorded in each 30 min.Finally,the ultrasonic images of the liver parenchyma at different time points were analyzed by DFY diagnostic ultrasound image analysis system.Another 10 healthy male SD rats were used as control group.Results With the increase of liver damage,the ASGPR content of liver tissue was decreased,there was significant difference between the groups(P<0.05);with the increase of injury degree,the peak echo intensity of liver was decreased,there was significant difference between the groups(P<0.05),except the normal control group and groupⅠ(P> 0.05).While there was no significant difference of time to peak,peak intensity,parenchyma intensity before enhancement and parenchyma intensity after wash-out of contrast agents(P> 0.05).Conclusion The imaging of liver injury with liquid perfluorocarbon nanoparticles ultrasound contrast agents targeted to liver cell membrane receptors ASGPR is excellent,the changes of peak intensity in ultrasound targeted imaging are consistant with those of ASGPR,which has benefit for quantitative evaluation of liver reserve function.

Visualization of therapeutic intervention for acute liver injury using low-intensity pulsed ultrasound-responsive phase variant nanoparticles

Preliminary experimental study on evaluation of liver injury by ultrasonic targeting imaging

Preclinical Validation of Silibinin/albumin Nanoparticles As an Applicable System Against Acute Liver Injury.

Hepatocyte-targeted hyaluronic acid-polyethyleneimine conjugates for acute liver injury therapy by ROS elimination and inflammation modulation

A ROS-Sensitive Nanozyme-Augmented Photoacoustic Nanoprobe for Early Diagnosis and Therapy of Acute Liver Failure

Construction of Phlorotannin-Based Nanoparticles for Alleviating Acute Liver Injury

Antioxidative Myricetin Enriched Nanoparticles towards Acute Liver Injury

Targeted Therapy of Acute Liver Injury via Cryptotanshinone-Loaded Biomimetic Nanoparticles Derived from Mesenchymal Stromal Cells Driven by Homing

Reactive Oxygen Species Scavenging Nanozymes: Emerging Therapeutics for Acute Liver Injury Alleviation

Curcumin-loaded Ceria Nanoenzymes for Dual-Action Suppression of Inflammation and Alleviation of Oxidative Damage in the Treatment of Acute Lung Injury

Efficacy of Ultrasound Microbubble-HGF Complex for Treating Hepatic Fibrosis and Its Relation with Perfusion Weighted Imaging

Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model.

In-situ evaluation the fluctuation of hypochlorous acid in acute liver injury mice models with a mitochondria-targeted NIR ratiometric fluorescent probe

Bile acid-based polydrug nanoparticles for the treatment of acute liver injury

Early Diagnosis of Liver Injury and Real‐Time Evaluation of Photothermal Therapy Efficacy with a Viscosity‐Responsive NIR‐II Smart Molecule

NIR-excited imaging of drug-induced liver injury using a superoxide-activated ratiometric upconversion luminescence nanoprobe

A Macrophage Membrane-Coated Cu-WO3- x-Hydro820 Nanoreactor for Treatment and Photoacoustic/Fluorescence Dual-Mode Imaging of Inflamed Liver Tissue

Integrin-Targeted Theranostic Nanoparticles for Clinical MRI-Traceable Treatment of Liver Fibrosis

Nano Ultrasound Contrast Agent for Synergistic Chemo‐photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis

Engineering of targeting antioxidant polypeptide nanopolyplexes for the treatment of acute lung injury

NIR triggered polydopamine coated cerium dioxide nanozyme for ameliorating acute lung injury via enhanced ROS scavenging